New York State’s largest health system adopts Philips patient monitoring platform to drive integration and innovation for a better patient and staff experience and improved outcomes
Dozee plans to further tap over 2,000 hospitals in more than 100 districts
The disease is caused by a mutation in the gene encoding HMG CoA reductase, inhibiting the enzyme’s activity.
First approved therapeutic regimen that combines an anti-PD-1 and an antibody-drug conjugate in the US in these patients
NDA supported by data from global Phase III FRESCO-2 study in the U.S., Europe, Japan and Australia along with data from Phase III FRESCO study conducted in China
Getinge has a strong market share in India within several product segments
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
Subscribe To Our Newsletter & Stay Updated